Excited to share our latest paper in Nature Cardiovascular Research showing #diabetic #cardiomyopathy is driven by aberrant #immunometabolism Enhancing Treg migratory capacity restores immune balance and improves🫀dysfunction a promising new therapeutic direction in T2D
www.nature.com/articles/s44...
Anderson et al. demonstrate that the glucokinase activator AZD1656 reduces inflammation and reverses cardiac dysfunction and metabolic remodeling in mice with diabetic cardiomyopathy.
